Home »
Academic Articles & Research Papers
Showing 20 of 81 academic articles
Bin Xiao, Lina Fu, Zhe Yang, Guran Yu • Journal of Health, Population and Nutrition
(2025)
Abstract Background This umbrella meta-analysis evaluates the effects of probiotics on cognitive function and metabolic health in Alzheimer’s disease (AD) and mild cognitive impairment (MCI) by synthesizing findings from meta-analyses of ra...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s41043-025-00816-3
Elliya Park, Lily Yi Li, Chunsheng He, Azhar Z. Abbasi et al. • Advanced Science
(2023)
Abstract Finding effective disease‐modifying treatment for Alzheimer's disease remains challenging due to an array of factors contributing to the loss of neural function. The current study demonstrates a new strategy, using multitargeted bi...
DOAJ
Open Access (DOAJ)
DOI: 10.1002/advs.202207238
Mahta Karimpoor, Nathan W. Churchill, Fred Tam, Corinne E. Fischer et al. • Frontiers in Human Neuroscience
(2018)
Handwriting is a complex human activity that engages a blend of cognitive and visual motor skills. Current understanding of the neural correlates of handwriting has largely come from lesion studies of patients with impaired handwriting. Tas...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fnhum.2018.00030
Camila Fabiani, Camila Fabiani, Silvia S. Antollini, Silvia S. Antollini • Frontiers in Cellular Neuroscience
(2019)
Biological membranes show lateral and transverse asymmetric lipid distribution. Cholesterol (Chol) localizes in both hemilayers, but in the external one it is mostly condensed in lipid-ordered microdomains (raft domains), together with satu...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fncel.2019.00309
Stewart F. Graham, Nolwen L. Rey, Zafer Ugur, Ali Yilmaz et al. • Metabolites
(2018)
For people with Parkinson’s disease (PD), considered the most common neurodegenerative disease behind Alzheimer’s disease, accurate diagnosis is dependent on many factors; however, misdiagnosis is extremely common in the prodrom...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/metabo8040071
Kirsten M. Wright, Janis McFerrin, Armando Alcázar Magaña, Armando Alcázar Magaña et al. • Frontiers in Nutrition
(2022)
Botanical products are frequently sold as dietary supplements and their use by the public is increasing in popularity. However, scientific evaluation of their medicinal benefits presents unique challenges due to their chemical complexity, i...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fnut.2021.799137
Addisu Getie, Melaku Bimerew, Mihretie Gedfew, Baye Tsegaye Amlak et al. • Archives of Gerontology and Geriatrics Plus
(2025)
Introduction: Cognitive impairment is a medical condition caused by neurodegeneration, marked by a gradual decline in neurological, motor, psychological, and cognitive domain functions, as well as daily activities. It primarily affects indi...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.aggp.2025.100171
Francesco Valeri, Malena dos Santos Guilherme, Fuqian He, Nicolai M. Stoye et al. • Microorganisms
(2021)
Alzheimer’s disease is a progressive neurodegenerative disorder affecting around 30 million patients worldwide. The predominant sporadic variant remains enigmatic as the underlying cause has still not been identified. Since efficient therap...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/microorganisms9122548
Xuehui Li, Pan Tang, Xinping Pang, Xianghu Song et al. • Scientific Reports
(2024)
Abstract Alzheimer's disease (AD) is a neurodegenerative disorder characterized primarily by cognitive impairment. The motivation of this paper is to explore the impact of the visual information transmission pathway (V–H pathway) on AD, and...
DOAJ
Open Access (DOAJ)
DOI: 10.1038/s41598-024-64099-0
Kecheng Li, Kecheng Li, Xiaoli Zhou, Xiaoli Zhou et al. • Frontiers in Endocrinology
(2024)
IntroductionBeta-amyloid accumulation in the brain appears to be a key initiating event in Alzheimer’s disease (AD), and factors associated with increased deposition of beta-amyloid are of great interest. Enhanced deposition of amyloid-β pe...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fendo.2024.1278477
Lauren E. McCollum, Sandhitsu R. Das, Long Xie, Robin de Flores et al. • NeuroImage: Clinical
(2021)
Mild cognitive impairment (MCI) can be an early manifestation of Alzheimer’s disease (AD) pathology, other pathologic entities [e.g., cerebrovascular disease, Lewy body disease, LATE (limbic-predominant age-related TDP-43 encephalopathy)], ...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.nicl.2021.102717
Themis P. Exarchos, Themis P. Exarchos, George A. Dimakopoulos, Konstantinos Lazaros et al. • Frontiers in Aging Neuroscience
(2025)
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fnagi.2025.1719723
Dandan Wang, Chang Xu, Wenxiao Wang, Hui Lu et al. • Brain Sciences
(2022)
Allele 4 of the apolipoprotein E gene (APOE ε4) and hypertension are considered risk factors for Alzheimer’s Disease (AD). The detection of differences in cognitive function and brain networks between hypertensive patients who are APOE ε4 c...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/brainsci12050515
Bunty Sharma, Deeksha Pal, Ujjawal Sharma, Aman Kumar • Frontiers in Molecular Neuroscience
(2022)
Mitochondria provide neurons not only energy as ATP to keep them growing, proliferating and developing, but they also control apoptosis. Due to their high bioenergetic demand, neurons which are highly specific terminally differentiated cell...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fnmol.2022.921908
Shahin Akhondzadeh • Europe PMC (PubMed Central)
(2015)
The rapid progress of modern biotechnology has presented a number of new and unique ethical and social challenges within the context of human medical science. Research in medical biotechnology has led to increased knowledge of disease, acce...
OPENALEX
Open Access
PMC: 4508337
Wiesje M. van der Flier • Journal of Neurology Neurosurgery & Psychiatry
(2005)
ementia refers to a syndrome that is characterised by progressive deterioration of cognitive functions.Neuropsychiatric symptoms, such as apathy, agitation, and depression, are also common.With increasing loss of function, a patient is grad...
OPENALEX
Open Access
DOI: https://doi.org/10.1136/jnnp.2005.082867
PMC: 1765715
Monique M.B. Breteler, Jules J. Claus, Cornelia M. van Duijn, Lenore J. Launer et al. • Epidemiologic Reviews
(1992)
Monique M. B. Breteler, Jules J. Claus, Cornelia M. van Duijn, Lenore J. Launer, Albert Hofman; Epidemiology of Alzheimer's Disease, Epidemiologic Reviews, Volu...
OPENALEX
Open Access
DOI: https://doi.org/10.1093/oxfordjournals.epirev.a036092
Scuderi SA, Basilotta R, Cucinotta L, Ardizzone A et al. • Journal of Inflammation Research
(2026)
Sarah Adriana Scuderi,1 Rossella Basilotta,2 Laura Cucinotta,2 Alessio Ardizzone,3 Emanuela Esposito21Genetics and Pharmacogenetics Unit, ‘Gaetano Martino’ University Hospital, Messina, Italy; 2Department of Chemical, Biological, Pharmaceut...
DOAJ
Open Access (DOAJ)
Fresthel Monica M Climacosa, Eric David B Ornos, Erwin Rommel S Diwa, Mary Gale R Guantia et al. • Journal of Alzheimer's Disease Reports
(2026)
Background The Monitoring drug Efficacy through Multi-Omics Research Initiative in Alzheimer's Disease (MEMORI-AD) study aims to characterize drug response to donepezil and memantine in a Filipino cohort with late-onset Alzheimer's disease ...
DOAJ
Open Access (DOAJ)
DOI: 10.1177/25424823261431318
• Oxford University Press eBooks
(2014)
Abstract Religious institutions and public health institutions seek to improve the well-being of their communities, many times with aligned interests but occasionally at odds with each other. This book explores for the first time the inters...
OPENALEX
DOI: https://doi.org/10.1093/acprof:oso/9780199362202.001.0001